Relmada Therapeutics (RLMD)'s 30-day implied volatility (IV30) was 82.0% at the close on November 4, 2026, down from 86.8% the day before, against a 52-week range of 46.4% to 151.1%. Its 20-day historical volatility was 72.0%.
Data as of November 4, 2026.